Wogonin could downregulate the expression of NRF2 as well as its target proteins HO-1, NADP(H), and NQO-1 to impair the NRF2-mediated antioxidant system and reverse DOX resistance in MCF-7ADR breast cancer cells [154]. Here, NFE2L2 is linked to breast cancer.